Get answers to your menopause and sexual dysfunction questions.
Polycystic ovaries; Polycystic ovary disease; Stein-Leventhal syndrome; Polyfollicular ovarian disease
Changes in the menstrual cycle:
Development of male sex characteristics (virilization):
Other skin changes:
During a pelvic examination, the health care provider may note an enlarged clitoris (very rare finding) and enlarged ovaries.
Diabetes, high blood pressure, and high cholesterol are common findings, as are weight gain and obesity.
Weight, body mass index (BMI), and abdominal circumference are helpful in determining risk factors.
Levels of different hormones that may be tested include:
Other blood tests that may be done include:
Other tests may include:
Bulun SE, Adashi EY. The physiology and pathology of the female reporductive axis. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR, eds. Williams Textbook of Endocrinology. 11th ed. Philadelphia, Pa: Saunders Elsevier; 2008:chap 16.
Radosh L. Drug treatments for polycystic ovary syndrome. Am Fam Physician. 2009;79:671-676.
Lobo RA. Hyperandrogenism: Physiology, etiology, differential diagnosis, management. In: Katz VL, Lentz GM, Lobo RA, Gershenson DM, eds. Comprehensive Gynecology. 5th ed. Philadelphia, Pa: Mosby Elsevier;2007:chap 40.
ACOG Practice Bulletin Number 108, October 2009. Accessed March 31, 2010.
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885